N. Higuchi

发表

SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.

K. Kotoh, R. Takayanagi, M. Nakamuta, 2008, International journal of molecular medicine.

Potential role of branched‐chain amino acids in glucose metabolism through the accelerated induction of the glucose‐sensing apparatus in the liver

K. Kotoh, R. Takayanagi, Tetsuhide Ito, 2011, Journal of cellular biochemistry.

Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study.

K. Kotoh, M. Nakashima, M. Nakamuta, 2008, International journal of molecular medicine.

Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study

T. Ide, H. Koga, K. Nagata, 2019, Cancer medicine.

The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.

Y. Maehara, K. Kotoh, M. Nakashima, 2008, International journal of molecular medicine.

Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study

T. Ide, H. Koga, K. Nagata, 2019, Hepatology International.

Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease.

K. Kotoh, R. Takayanagi, M. Nakamuta, 2011, Experimental and therapeutic medicine.

Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease.

Y. Maehara, K. Kotoh, M. Nakashima, 2009, International journal of molecular medicine.

SREBP-1 c , regulated by the insulin and AMPK signaling pathways , plays a role in nonalcoholic fatty liver disease

K. Kotoh, R. Takayanagi, M. Nakamuta, 2022 .

The effects of unsaturated fatty acids on lipid metabolism in HepG2 cells

K. Kotoh, M. Nakashima, M. Nakamuta, 2009, In Vitro Cellular & Developmental Biology - Animal.

[A case of hepatocellular carcinoma with respiratory failure caused by widespread tumor microemboli].

R. Takayanagi, S. Aishima, N. Higuchi, 2011, Fukuoka igaku zasshi = Hukuoka acta medica.

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study

M. Nakamuta, M. Kohjima, Tsuyoshi Yoshimoto, 2022, Medicine.

NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells

K. Kotoh, M. Nakamuta, M. Kohjima, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Methylprednisolone injection via the portal vein suppresses inflammation in acute liver failure induced in rats by lipopolysaccharide and d‐galactosamine

K. Kotoh, R. Takayanagi, S. Aishima, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Reduced hepatic expression of adipose tissue triglyceride lipase and CGI-58 may contribute to the development of non-alcoholic fatty liver disease in patients with insulin resistance

M. Enjoji, N. Higuchi, Masaki Kato, 2008, Scandinavian journal of gastroenterology.

Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway.

Y. Maehara, K. Kotoh, T. Nishinakagawa, 2010, International journal of clinical pharmacology and therapeutics.

Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma

M. Nakamuta, M. Kohjima, Tsuyoshi Yoshimoto, 2022, Internal medicine.

Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.

K. Kotoh, R. Takayanagi, M. Nakamuta, 2007, International journal of molecular medicine.

X chromosome contribution to the genetic architecture of primary biliary cholangitis.

Aaron M. King, Elizabeth G. Atkinson, K. Siminovitch, 2021, Gastroenterology.

The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression

Y. Maehara, K. Kotoh, M. Nakashima, 2009, Hepatology international.

Liver X receptor in cooperation with SREBP‐1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease

K. Kotoh, R. Takayanagi, M. Nakamuta, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: a novel target for therapy?

Y. Maehara, K. Kotoh, T. Nishinakagawa, 2009, International journal of molecular medicine.

An increase in the serum amylase level in patients after peroral double-balloon enteroscopy: an association with the development of pancreatitis

R. Takayanagi, Tetsuhide Ito, Y. Sumida, 2006, Endoscopy.

Investigation of hyperuricemia during pegylated‐interferon‐α2b plus ribavirin combination therapy in patients with chronic hepatitis C

N. Kinukawa, K. Kotoh, R. Takayanagi, 2008, Journal of digestive diseases.

Impact of double-balloon endoscopy on the diagnosis of jejunoileal involvement in primary intestinal follicular lymphomas: a case series.

R. Takayanagi, Kazuhiko Nakamura, Y. Sumida, 2009, Endoscopy.